Clinical Trial Update: Study of CRx-191 to Assess Activity in Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial of CRx-191 in plaque psoriasis has completed, with activity assessed; detailed results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CRx-191 (CRx-191)

Snippet

Sponsor: Zalicus | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED